Veracyte | VCYT - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Agenus USD 34.2M 4.61M 2025-12
Agilent USD 990M 44M 2026-03
Anika Therapeutics USD 19.18M 3.6M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Bruker USD 379.8M 69.4M 2026-03
Heron Therapeutics USD 29.47M 3.17M 2025-12
Illumina USD 721M 38M 2026-03
Intrexon USD -297K 167K 2024-06
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Laboratory Of America USD 1.01B 20.6M 2026-03
Ligand Pharmaceuticals USD 48.45M 8.22M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Roche Holding CHF 22.09B 10.04B 2025-12
Sangamo BioSciences -2.39M 1.09M 2024-06
Siemens EUR 7.63B 471M 2025-12
Sonic Healthcare AUD 3.92B 3.14B 2024-12
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Veracyte USD 101.16M 814K 2026-03
Waters USD 542M 15.42M 2026-03